S 1427 · 117th Congress 2021โ€“2023, ended

Increasing Access to Biosimilars Act of 2021

Latest action · Apr 28, 2021 Read twice and referred to the Committee on Finance.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 28, 2021
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Increasing Access to Biosimilars Act of 2021

This bill requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead.

Cosponsors 1

Members who signed on, in the order they did. All signed on Apr 28, 2021.

SeatCosponsorSigned on
D-COMichael F. BennetOriginalApr 28, 2021

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateFinance Committee
Referred Apr 28, 2021

Actions 2

Everything that happened, newest first.

  1. Apr 28, 2021Introduced in Senate
  2. Apr 28, 2021Read twice and referred to the Committee on Finance.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 117-809PRESCRIPTION DRUG PRICE INFLATION: AN URGENT NEED TO LOWER DRUG PRICES IN MEDICARE224 pagesFinance CommitteeMar 16, 2022
S. Hrg. 117-595THE PRESIDENT'S FISCAL YEAR 2022 HHS BUDGET109 pagesFinance CommitteeJun 10, 2021

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 2869Increasing Access to Biosimilars Act of 2021Related billApr 29, 2021

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.
Short Title(s) as Introduced
Increasing Access to Biosimilars Act of 2021

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Apr 28, 2021Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.